The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy.
Kidney Int
; 99(4): 986-998, 2021 04.
Article
em En
| MEDLINE
| ID: mdl-33166580
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Glomerulonefrite Membranosa
/
Tacrolimo
Limite:
Humans
Idioma:
En
Ano de publicação:
2021